A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...
By HealthDay Staff HealthDay ReporterWEDNESDAY, March 11, 2026 (HealthDay News) — From cobblers to smoothies, dark sweet ...
The powerful gene-editing technique CRISPR–Cas9 might offer a way to make safer, more effective cancer-fighting immune cells ...
New findings have challenged long-held beliefs about cancer and aging. A study, conducted on mice by Stanford Medicine researchers, found that the elderly seem to be at a lower risk for the disease, ...
The finding suggests other chemo drugs, too, may be making cancer cells cause a surprising immune-system reaction.
Every year, millions of people are diagnosed with cancer globally; however, current treatments are limited by disease complexity. A study published in the open-access journal in PLOS Biology by Tianyu ...
SAN FRANCISCO—The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a ...
The targeted cancer therapy using bacteria could be much less toxic than traditional treatments, research team says in paper Chinese scientists say they have turned E coli into a cancer therapy that ...
In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant weight loss in obese mice but also slashed breast cancer tumor growth. The ...
Share on Pinterest Chemicals in cigarette smoke may promote the growth and spread of tumors in pancreatic cancer, a new mouse study shows. Bob Thomas/Getty Images Prior research has linked smoking to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results